AMPHIVENA RESTORE
DEAD

Serial Number

90282216

Owner

Amphivena Therapeutics, Inc.

Attorney

Lisa Greenwald-Swire

Filing Date

Oct 27, 2020

Add to watchlist:

No watchlists yet
View on USPTO

AMPHIVENA RESTORE Trademark

Serial Number: 90282216

AMPHIVENA RESTORE is a trademark filed by Amphivena Therapeutics, Inc. on October 27, 2020. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Amphivena Therapeutics, Inc. (2 trademarks)

Two Tower Place, Suite 1000
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

October 27, 2020

Registration Date

Not Registered

Published for Opposition

May 18, 2021

Goods & Services

Laboratory research in the field of polypeptides, particularly antibodies and antibody derivatives; product development, in the field of medicaments, namely, polypeptides, particularly antibodies and antibody derivatives, for use in the treatment of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host disease, transplant rejection, coronary heart diseases and minimal residual diseases; product development, in the field of diagnostic and testing apparatus and instruments for the identification of tumorous diseases, allergies, autoimmunity, inflammation, infectious diseases, osteoporosis, graft versus host diseases, transplant rejection, coronary heart diseases and minimal residual diseases, and for the identification of expressed genes, particularly of abnormal expressed genes, for the analysis and identification of the gene expression pattern and eukaryotic cells, particularly of single cells and cell culture lines, particularly of mammalian and human cells, particularly of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with laser, of cells isolated with FACS or with receptor to ligand binding, of chemical fixed tissue, of micrometastatic cells, of bone marrow cells, of samples of body fluids, particularly from liquor, blood, lymph, urine or bowel movement, of stem cells, cloned single cells or differentiated stages from specific cells

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 14, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 14, 2022 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 13, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 18, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 18, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 28, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 12, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 12, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 12, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 12, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 12, 2021 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 8, 2021 GNRN
NON-FINAL ACTION E-MAILED
Apr 8, 2021 GNRT
NON-FINAL ACTION WRITTEN
Apr 8, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 26, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 18, 2020 NWOS
NEW APPLICATION ENTERED
Oct 30, 2020 NWAP